Quick Answer
Sight Sciences, Inc. reported Cash And Cash Equivalents At Carrying Value of $91.97 million for the year ending 2025.
- Sight Sciences, Inc. showed a decrease of -23.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Sight Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $35.57 million | Q3 2021: $271.48 million | Q1 2022: $238.59 million | Q2 2022: $220.10 million | Q3 2022: $199.82 million | Q1 2023: $167.34 million | Q2 2023: $154.52 million | Q3 2023: $144.50 million | Q1 2024: $127.28 million | Q2 2024: $118.18 million | Q3 2024: $118.56 million | Q1 2025: $108.77 million | Q2 2025: $101.50 million | Q3 2025: $92.37 million.
- Over the full 6 years of available data (2020 to 2025), Sight Sciences, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 49.5%.
- Historical annual values: Fiscal year 2025: $91.97 million | Fiscal year 2024: $120.36 million | Fiscal year 2023: $138.13 million | Fiscal year 2022: $185.00 million | Fiscal year 2021: $260.69 million | Fiscal year 2020: $61.51 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: